• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharmaceuticals

MYL:US

47.2100 USD 0.9800 2.12%

As of 20:10:00 ET on 04/16/2014.

Snapshot for Mylan Inc/PA (MYL)

Open: 46.8800 Day's Range: 46.3500 - 47.3100 Volume: 4,055,353
Previous Close: 46.2300 52wk Range: 27.6550 - 57.5200 1-Yr Rtn: +68.49%

Stock Chart for MYL

No chart data available.
  • MYL:US 47.2100
  • 1D
  • 1M
  • 1Y
46.2300
Interactive MYL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MYL

Current P/E Ratio (ttm) 25.5719
Estimated P/E(12/2014) 13.6920
Relative P/E vs. SPX 1.4879
Earnings Per Share (USD) (ttm) 1.8462
Est. EPS (USD) (12/2014) 3.4480
Est. PEG Ratio 1.2074
Market Cap (M USD) 17,557.99
Shares Outstanding (M) 371.91
30 Day Average Volume 6,683,424
Price/Book (mrq) 5.9635
Price/Sale (ttm) 2.6172
Dividend Indicated Gross Yield -%
Cash Dividend (USD) -
Dividend Ex-Date 07/17/2007
5 Year Dividend Growth -
Next Earnings Announcement 05/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MYL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MYL

Mylan Inc. is a global generic and specialty pharmaceuticals company. The Company operates an active pharmaceutical ingredient manufacturer and runs a specialty business focused on respiratory, allergy, and psychiatric therapies.

Robert J CouryChairmanRodney L PiattVice Chairman
Heather BreschChief Executive OfficerRajiv MalikPresident
More Company Profile & Key Executives for MYL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil